i.c.v. delivery of AAV9-synapsin-promoted caveolin-1 attenuates neuromuscular deficits and neuromuscular degeneration in hSOD1G93A mice
Molecular Therapy Advances
· Elsevier
Аннотация
Publication date: 10 September 2026 Source: Molecular Therapy Advances, Volume 34, Issue 3 Author(s): Noriyuki Watanabe, Yumi Kawahori, Vinh Ta, Dongsheng Wang, Kenneth A. Ohgi, Hongxia Wang, Natalia Kleschevnikova, Eiichi Ishikawa, Brian P. Head
Читать у издателя →
Цитирование
i.c.v. delivery of AAV9-synapsin-promoted caveolin-1 attenuates neuromuscular deficits and neuromuscular degeneration in hSOD1G93A mice. // Molecular Therapy Advances. – URL: https://www.sciencedirect.com/science/article/pii/S3117387X26001552?dgcid=rss_sd_all
i.c.v. delivery of AAV9-synapsin-promoted caveolin-1 attenuates neuromuscular deficits and neuromuscular degeneration in hSOD1G93A mice. Molecular Therapy Advances. https://www.sciencedirect.com/science/article/pii/S3117387X26001552?dgcid=rss_sd_all
“i.c.v. delivery of AAV9-synapsin-promoted caveolin-1 attenuates neuromuscular deficits and neuromuscular degeneration in hSOD1G93A mice.” Molecular Therapy Advances.
@article{article119251,
title = {i.c.v. delivery of AAV9-synapsin-promoted caveolin-1 attenuates neuromuscular deficits and neuromuscular degeneration in hSOD1G93A mice},
journal = {Molecular Therapy Advances},
url = {https://www.sciencedirect.com/science/article/pii/S3117387X26001552?dgcid=rss_sd_all}
}